Sona Nanotech Inc C.SONA

Alternate Symbol(s): SNANF

Technology Scientific & Technical Instruments

Sona Nanotech Inc. is a nanotechnology life sciences company, which is engaged in developing targeted hyperthermia therapy. The Company has developed multiple methods for the manufacturing of various types of gold nanoparticles (GNR). It is engaged in research and development of its technology for use in multiplex diagnostic testing platforms and advanced biomedical applications. Its gold nanotechnologies are adapted for use in applications, as a safe and delivery system for multiple medical treatments, for the approval of various regulatory boards, including Health Canada and the Food and Drug administration (FDA). Its gold nanorod particles are manufactured without the use of cetyltrimethylammonium bromide (CTAB), eliminating the toxicity risks associated with the use of other gold nanorod technologies in medical applications. The Company is focused on the development of a pre-clinical nanomedical therapy for the treatment of cancer using its biocompatible GNR.

CSE:SONA - Post by User

Sona Nanotech Inc

Bullboard Posts

Post by wintraderon Oct 09, 2020 8:53am

289 Views

Post# 31694712

SONA in Journal of Experimental Biology and Agricultural

This was written in the Journal : Have a look !!! Another evidence it's coming ...

Similarly the study also suggest, Sona Nanotech (Halfax, Canada) in collaboration with GE Health Life Sciences has been working on the S protein (S1 domain) of the virus in developing a rapid immunoassay that could detect antigens of SARS-CoV-2 in about 5-15 minutes and (Lee et al., 2020). The recent study done by Carter et al., 2020 suggest that Canada has approved Rapid SARS-CoV-2 antigen detection test developed by Nova Scotiathat detect S1 domain of S protein in nasal swab. The study also suggest many antigen

file:///C:/Users/Daniel/Downloads/CoronaViruses.pdf

Bullboard Posts

How one company is disrupting PoC testing